Search
for
Sort by
Research 511–540 of 1000+
- Loose anagen hair syndrome: Treatment with systemic minoxidil characterised by marked hair colour change
- Chronic telogen effluvium or early androgenetic alopecia?
- Single hair analysis by X-ray fluorescence spectrometry detects small changes in dietary zinc intake: A nested randomized controlled trial
- Response of alopecia areata of the beard to oral tofacitinib
- The hair shaft: normality, abnormality, and genetics
- Recalcitrant lichen planopilaris and frontal fibrosing alopecia responding to tildrakizumab
- An In Vitro Model for the Morphogenesis of Hair Follicle Dermal Papillae
- Location of keratin-associated proteins in developing fiber cuticle cells using immunoelectron microscopy
- Shortness of breath: an uncommon side-effect of cyproterone acetate in the treatment of androgenetic alopecia
- Chronic telogen effluvium in a man
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Low‐dose oral minoxidil improves global hair density and length in children with loose anagen hair syndrome
- Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
- Human melanocyte development and melanoma dedifferentiation at single cell resolution
- Oral minoxidil bio‐activation by hair follicle outer root sheath cell sulfotransferase enzymes predicts clinical efficacy in female pattern hair loss
- Winding the clock back on female androgenetic alopecia
- Use of spironolactone in dermatology.
- Male androgenetic alopecia (Part II)
- Hirsuties
- Gonadal Dysgenesis: Associations between Clinical Features and Sex of Rearing.
- Assessment of clinician-reported outcome measures for alopecia areata: a systematic scoping review
- Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes
- Prostaglandins in androgenetic alopecia in 12 men and four female
- Short anagen hair naevus: improvement after treatment with 5% topical minoxidil
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- How storage post sampling influences the stability of sebum when used for mass spectrometry metabolomics analysis?
- A Plain Language Summary on Ritlecitinib Treatment for Adults and Adolescents with Alopecia Areata
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Shedding light on therapeutics in alopecia and their relevance to COVID-19